Mysterious fever outbreak in Uttarakhand: 10 dead in 15 days across Almora and Haridwar

Patients affected by the illness have presented with a high fever and a concerning drop in platelet count, a symptom often ...
The Express Tribune on MSN

Seasonal ailments grip Karachi

Seasonal ailments grip metropolis ...

Uttarakhand Hit by Mysterious Fever Outbreak; 10 Dead in Almora and Haridwar

A mysterious fever outbreak in Uttarakhand has claimed 10 lives within a fortnight, affecting the districts of Almora and ...
University at Buffalo

Fatty liver disease is a growing, silent epidemic, especially among younger patients, says UB physician

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s ...
Men's Health Magazine Australia

Future follicles: the groundbreaking breakthroughs helping to regrow hair

For many, hair loss is an inevitable part of getting older — but thanks to new breakthroughs, it doesn’t have to be ...
CURE

Enhertu Reduces Risk of Invasive Disease or Death in HER2+ Breast Cancer

Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...

Sanofi (SAN:CA) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call October 24, 2025 8:30 AM EDTCompany ParticipantsThomas Larsen - Head of Investor RelationsPaul Hudson - CEO ...
The Malaysian Reserve

Lilly’s Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...
Jacobs School of Medicine and Biomedical Sciences - University at Buffalo

Fatty Liver Disease a Growing Epidemic, Says UB Physician

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s fastest-growing diseases. And it’s increasingly occurring in young people ...

ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...